Adopt a Regulatory-Compliant Flow Chemistry Strategy to Increase ROI, Optimize Your Drug Substance Development & Streamline Commercial Manufacturing
Don’t let physical barriers limit our collaboration & Knowledge sharing – Join us at this Unique & Exclusive Virtual Summit this August. Adopt a Regulatory-Compliant Flow Chemistry Strategy to Increase ROI, Optimize Your Drug Substance Development & Streamline Commercial Manufacturing
The inaugural Commercializing Flow Chemistry Summit is your catalyst to bridge the gap between using flow for a single step in R&D to supporting fully integrated GMP drug substance manufacturing, from technical, economic and regulatory standpoints.
The Commercializing Flow Chemistry Summit is a drug substance & small molecule specific forum for the advancement of flow chemistry in Pharma. If you’re looking to discuss flow outside of the academic lab and the realities of implementing continuous flow in a commercial setting, log in and join CFC.
Navigate an emerging and complex regulatory landscape
Tackle stakeholder engagement in an effective manner
Advance your control strategy, PAT and form practical and precise models
Find your flow partners in external manufacturing and reactor design
The latest data from enabling chemistry and photo/redox results
Evaluate end-to-end continuous processing and integration of API production with downstream
Automation and modularization in continuous flow chemistry scale up
Testimonials from our AFM Series
"Great opportunity to network, good representation of industry state-of-the-art in continuous processing, Principal Process." Development Scientist, Amgen, Past CCP Attendee
"Very comprehensive conference covering all aspects of continuous processing from regulatory through final drug product manufacturing."
VP R&D, Ampac Fine Chemicals LLC, Past CCP Attendee
"The conference was enlightening and also reiterated information on the status of Continuous manufacturing processes in our industry."
Senior Scientist, BARDA, Past CCP Attendee
"Very enlightening and well organized conference!"
Senior Director of Chemical Engineering, Asymchem, Past CCP Attendee
Expert Speakers Include:
Flavien Susanne
Head of Product Development
Expert in Development and Industrialization of Continuous Processing
Pierre Boulas
Senior Director, Head of Pharmaceutical Development; Chair Emeritus
Biogen; IQ Consortium
